Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_assertion description "[Furthermore, NEFL physically associated with tuberous sclerosis complex 1 (TSC1), a known inhibitor of the mTOR pathway, and NEFL downregulation led to functional activation of mTOR pathway and consequentially conferred cisplatin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_assertion evidence source_evidence_literature NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_assertion SIO_000772 22246235 NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_assertion wasDerivedFrom befree-2016 NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_assertion wasGeneratedBy ECO_0000203 NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.
- befree-2016 importedOn "2016-02-19" NP953317.RAOjRbXMavO5F2Im62j1MVA1a3JEnI2pUQ2Jc2OFXa6JM130_provenance.